New Treatment
Last Tuesday, after almost two months away, I headed back to the cancer center to meet with my oncologist and begin a new treatment. What that new treatment was going to be, I didn't know. I hadn't been able to have the blood biopsy recommended by Johns Hopkins before our trip to England, so I knew I wouldn't be starting Enhertu, the treatment that biopsy might show I'm a candidate for. But I felt relief knowing that it no longer matters which order I try treatments in and that trying one doesn't mean I'm burning my bridges for trying another. I went in with an open mind to hear my oncologist's plan. His thinking was still the same - try a new chemo my cancer has never seen (carboplatin) and combine it with an immunotherapy drug (Avastin), which is a whole class of drugs my cancer has also never seen. Cancer is tricky and his thought is to be tricky ourselves - coming at the cancer from a new direction. His strong preference was not to repeat paclitaxel, the